AI Research Team
April 9, 2026
In the landscape of scientific procurement, the Certificate of Analysis (COA) serves as the primary bridge between a synthesized chemical and a verified research reagent. Because the research peptide market operates with variable manufacturing oversight, the burden of quality assurance rests on the researcher. A COA is not merely a marketing document; it is an analytical record that, when read correctly, provides empirical evidence of a compound’s identity and purity.
This guide outlines the technical requirements for evaluating a COA, moving beyond the surface-level percentage to the raw data that supports a legitimate report.
A comprehensive COA must move beyond simple assertions of quality. According to industry standards for analytical documentation, a credible report should include four primary data points [peptideprotocolwiki.com](https://www.peptideprotocolwiki.com/blog/peptide-coa-testing-guide):
* Identity: Confirms that the molecular weight of the substance matches the intended sequence. * Purity: Quantifies the relative amount of the target peptide against impurities. * Content: Specifies the net peptide content (the actual amount of peptide versus salt and water). * Contaminants: Reports on impurities like heavy metals or endotoxins, which are critical for in vitro or in vivo experimental validity [peptidings.com](https://peptidings.com/guides/coa/).
High-Performance Liquid Chromatography (HPLC) is the standard method for determining the purity of a peptide. It functions by separating the sample into its constituent components based on their chemical properties.
Red Flags to Identify: * Co-elution: If the chromatogram shows a single, massive peak with no baseline separation, the analytical method may be insufficient to detect minor impurities. * A COA provided without the raw chromatogram data should be considered incomplete [cernumbiosciences.com/blogs/peptide-science-guide/hplc-ms-amp-coas-peptide-testing-methods-explained](https://cernumbiosciences.com/blogs/peptide-science-guide/hplc-ms-amp-coas-peptide-testing-methods-explained).
Source
Peptide Protocol WikiWhile HPLC measures purity, Mass Spectrometry (MS) confirms identity. MS measures the mass-to-charge ratio of the ionized molecules in the sample. A researcher must compare the “Observed MW” reported on the COA against the “Theoretical MW” of the target peptide sequence.
If the observed molecular weight deviates significantly from the theoretical weight, the synthesis likely produced an incorrect sequence or a truncated fragment. A failure here renders the purity percentage irrelevant, as the sample is not the intended reagent [peptidings.com](https://peptidings.com/guides/coa/).
The source of the COA is a critical variable in assessing risk. Manufacturer-generated COAs are internal quality controls and are subject to inherent conflicts of interest.
Third-party testing, conducted by an independent laboratory with no financial stake in the outcome, provides a higher degree of objective verification. Researchers should prioritize vendors who utilize transparent, third-party analytical labs, as these documents are less likely to be doctored or selectively reported [peptideprotocolwiki.com](https://www.peptideprotocolwiki.com/blog/peptide-coa-testing-guide).
Before accepting a peptide for laboratory use, verify the following:
Verification of research materials is a fundamental component of the scientific method. By shifting focus from vendor marketing claims to the raw data provided in a COA—specifically the chromatogram and mass spectrometry results—researchers can significantly reduce the risk of experimental failure. Always treat the COA as a chain of evidence, and when in doubt, request the raw analytical data from the supplier.